The New England Patriots have re-signed defensive tackle Jeremiah Pharms Jr. to a two-year, $2.475 million deal, which includes $350,000 in guarantees. However, despite this extension, his spot on the 2025 roster remains uncertain due to contract terms that allow for an easy release without major salary cap implications. Pharms, who is 29 and coming off a strong season, received a deal that mirrors exclusive rights free agent tender but also includes some additional guarantees, reflecting the team's confidence in his potential performance.
The Patriots signed DT Jeremiah Pharms Jr. to a two-year, $2.475 million contract extension, but his future on the roster remains uncertain.
Despite receiving guarantees in his new contract, Pharms Jr. could still be released without significant salary cap consequences for the team.
Pharms Jr.'s $1,030,000 base salary in 2025 mirrors the ERFA tender, but extra guarantees indicate the team’s confidence in his abilities.
While his contract adds to the roster, his future is contingent on performance, and the Patriots are still heavily under the salary cap.
Collection
[
|
...
]